Clinical trial
Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid Arthritis
NCT04842981 is registered in ClinicalTrials.gov with University of Southern Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid Arthritis
- Lead sponsor
- University of Southern Denmark
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- May 25, 2021
- Completion date
- September 30, 2022
- Enrollment
- 3 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
arthritis, rheumatoid, interaction